Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial.
Carol L Armour, Helen K Reddel, Kate S LeMay...
https://pubmed.ncbi.nlm.nih.gov/23270495/Actively Recruiting
Led by Karolinska Institutet · Updated on 2026-08-07
80
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are evaluating an app-based medical device designed to improve inhalation techniques in patients with asthma and COPD. The study aims to compare this app-based education and training with standard care over a 6-12 week period. The trial focuses on whether the app can increase the rate of successful inhalation techniques, which is important for effective treatment and symptom control in respiratory diseases. This research also assesses the feasibility, usability, and safety of the medical device during its use. Participants are randomly assigned to one of two groups one receiving standard care plus app-based education and training using the inhalation app-module embedded in the AsthmaTuner system, and the other receiving standard education without the app. The app uses a Bluetooth-connected spirometer and an adjustable resistance device to simulate inhaler resistance and measure inhalation flow. Training includes instructions, real-time feedback, and educational quizzes. Both groups receive initial inhalation technique assessment and training by a respiratory nurse, with follow-up at 6-12 weeks. During the study, participants use the app and device regularly to practice inhalation techniques. Researchers assess inhalation success by measuring peak inspiratory flow, time to peak flow, inhalation time, and breath holding, along with subjective criteria of correct device handling. Questionnaires and interviews collect data on the devices feasibility and patient experience. The main outcome is the rate of successful inhalation technique at the 6-12 week follow-up. The study involves 80 subjects aged 16 and older who use dry powder inhalers or metered dose inhalers daily for asthma or COPD.
CONDITIONS
APP-based Medical Device for Education and Training of Inhalation Technique
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Karolinska Institutet
Lead Sponsor
Uppsala University Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or digital)
Duration - 6 to 12 weeks
Participants receive either app-based education and training on inhalation technique using a connected spirometer device or standard inhaler education without the app.
Regular use of app and device with follow-up assessment at 6-12 weeks
Duration - 1 day
Participants attend a follow-up visit where inhalation technique is assessed using objective measurements and subjective criteria.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Carol L Armour, Helen K Reddel, Kate S LeMay...
https://pubmed.ncbi.nlm.nih.gov/23270495/Sven-Arne Jansson, Eva Rönmark, Bertil Forsberg...
https://pubmed.ncbi.nlm.nih.gov/17689234/Henrik Ljungberg, Anna Carleborg, Hilmar Gerber...
https://pubmed.ncbi.nlm.nih.gov/31481605/Mariëlle E A C Broeders, Walter Vincken, Lorenzo Corbetta...
https://pubmed.ncbi.nlm.nih.gov/21808941/Kai Richter
https://pubmed.ncbi.nlm.nih.gov/15481285/G K Crompton, P J Barnes, M Broeders...
https://pubmed.ncbi.nlm.nih.gov/16495040/Mariëlle E A C Broeders, Johan Molema, Wim C J Hop...
https://pubmed.ncbi.nlm.nih.gov/15588037/Louis-Philippe Boulet, J Mark FitzGerald, Mark L Levy...
https://pubmed.ncbi.nlm.nih.gov/22282546/Iman A Basheti, Helen K Reddel, Carol L Armour...
https://pubmed.ncbi.nlm.nih.gov/17433831/Klaus F Rabe, Suzanne Hurd, Antonio Anzueto...
https://pubmed.ncbi.nlm.nih.gov/17507545/Karolinska Institutet
Lead Sponsor
Uppsala University Hospital
Collaborating Sponsor